Article info

Download PDFPDF

Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry

Authors

  1. Correspondence to Professor Thomas Bauernhofer, Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz 8036, Austria; thomas.bauernhofer{at}medunigraz.at
View Full Text

Citation

Kammerer S, Jahn SW, Winter E, et al
Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry

Publication history

  • Received April 8, 2016
  • Revised June 2, 2016
  • Accepted June 9, 2016
  • First published October 3, 2016.
Online issue publication 
November 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.